Although potentially life-saving in hemorrhaging trauma patients, autologous salvage of enteric-contaminated blood for reinfusion has been considered contraindicated. With considerable literature support for its use and ethics committee approval, Bowley and colleagues from Johannesburg, Republic of South Africa, conducted a prospective randomized controlled trial investigating intraoperative blood salvage (IBS) as a means of reducing allogeneic blood transfusion in penetrating abdominal trauma.